今日，创新药板块集体发力，CXO方向领涨。截至收盘，睿智医药、九洲药业涨停，药石科技涨超18%，南新制药涨超17%，药明康德、康龙化成等纷纷上涨。消息面上，药明康德昨夜发布半年报并上调全年销售预期。药明康德公告称，预计2025年持续经营业务收入重回双位数增长，增速从10-15%上调至13-17%，预计全年整体收入从人民币415-430亿元上调至人民币425-435亿元。公司表示，将持续聚焦...
Source Link今日，创新药板块集体发力，CXO方向领涨。截至收盘，睿智医药、九洲药业涨停，药石科技涨超18%，南新制药涨超17%，药明康德、康龙化成等纷纷上涨。消息面上，药明康德昨夜发布半年报并上调全年销售预期。药明康德公告称，预计2025年持续经营业务收入重回双位数增长，增速从10-15%上调至13-17%，预计全年整体收入从人民币415-430亿元上调至人民币425-435亿元。公司表示，将持续聚焦...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.